143 related articles for article (PubMed ID: 34910889)
21. Upregulated expression of SAC3D1 is associated with progression in gastric cancer.
Liu AG; Zhong JC; Chen G; He RQ; He YQ; Ma J; Yang LH; Wu XJ; Huang JT; Li JJ; Mo WJ; Qin XG
Int J Oncol; 2020 Jul; 57(1):122-138. PubMed ID: 32319600
[TBL] [Abstract][Full Text] [Related]
22. Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.
Dai J; Li ZX; Zhang Y; Ma JL; Zhou T; You WC; Li WQ; Pan KF
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00004. PubMed ID: 30702489
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
Ahadi A
IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
[TBL] [Abstract][Full Text] [Related]
24. NGS Data Repurposing Allows Detection of tRNA Fragments as Gastric Cancer Biomarkers in Patient-Derived Extracellular Vesicles.
Maqueda JJ; Santos M; Ferreira M; Marinho S; Rocha S; Rocha M; Saraiva N; Bonito N; Carvalho J; Oliveira C
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240307
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
[TBL] [Abstract][Full Text] [Related]
27. Identification of specific modules and hub genes associated with the progression of gastric cancer.
Gong C; Hu Y; Zhou M; Yao M; Ning Z; Wang Z; Ren J
Carcinogenesis; 2019 Oct; 40(10):1269-1277. PubMed ID: 30805585
[TBL] [Abstract][Full Text] [Related]
28. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
29. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
Ma Z; Xu J; Ru L; Zhu W
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
[TBL] [Abstract][Full Text] [Related]
30. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
31. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
[TBL] [Abstract][Full Text] [Related]
32. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
[TBL] [Abstract][Full Text] [Related]
33. Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
Fei HJ; Chen SC; Zhang JY; Li SY; Zhang LL; Chen YY; Chang CX; Xu CM
Int J Oncol; 2018 Mar; 52(3):955-966. PubMed ID: 29328368
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods.
Wang J; Gao P; Song Y; Sun J; Chen X; Yu H; Wang Y; Wang Z
J Cell Mol Med; 2018 Nov; 22(11):5743-5747. PubMed ID: 30133128
[TBL] [Abstract][Full Text] [Related]
35. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer.
Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH
Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391
[TBL] [Abstract][Full Text] [Related]
36. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
[TBL] [Abstract][Full Text] [Related]
38. Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.
Kohmoto T; Masuda K; Shoda K; Takahashi R; Ujiro S; Tange S; Ichikawa D; Otsuji E; Imoto I
Gastric Cancer; 2020 May; 23(3):403-417. PubMed ID: 31654186
[TBL] [Abstract][Full Text] [Related]
39. Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
Yin Z; Wu D; Shi J; Wei X; Jin N; Lu X; Ren X
BMC Cancer; 2020 Nov; 20(1):1062. PubMed ID: 33148208
[TBL] [Abstract][Full Text] [Related]
40. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]